Back to Journals » OncoTargets and Therapy » Volume 15

Anlotinib Hydrochloride and PD-1 Blockade as a Salvage Second-Line Treatment in Patients with Progress of Local Advanced Non-Small Cell Lung Cancer in Half a Year After Standard Treatment

Total article views   HTML views PDF downloads Totals
4,390 Dovepress* 4,050+ 109 4,159
PubMed Central* 340 123 463
Totals 4,390 232 4,622
*Since 17 October 2022
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar